Login / Signup

Commentary: minimum reporting standards should be expected for preclinical radiobiology irradiators and dosimetry in the published literature.

François TrompierLarry A DeWerdYannick P PoirierMorgane Dos SantosKe ShengKeith A KunugiThomas A WintersAndrea Lynn DiCarloMerriline M Satyamitra
Published in: International journal of radiation biology (2023)
The cornerstones of science advancement are rigor in performing scientific research, reproducibility of research findings and unbiased reporting of design and results of the experiments. For radiation research, this requires rigor in describing experimental details as well as the irradiation protocols for accurate, precise and reproducible dosimetry. Most institutions conducting radiation biology research in in vitro or animal models do not have describe experimental irradiation protocols in sufficient details to allow for balanced review of their publication nor for other investigators to replicate published experiments. The need to increase and improve dosimetry standards, traceability to National Institute of Standards and Technology (NIST) standard beamlines, and to provide dosimetry harmonization within the radiation biology community has been noted for over a decade both within the United States and France. To address this requirement subject matter experts have outlined minimum reporting standards that should be included in published literature for preclinical irradiators and dosimetry.
Keyphrases
  • monte carlo
  • adverse drug
  • systematic review
  • radiation induced
  • public health
  • healthcare
  • mental health
  • cell therapy
  • meta analyses
  • stem cells
  • emergency department
  • radiation therapy
  • mass spectrometry
  • bone marrow